Clinical relevance of detectable HCV RNA in the context of direct acting antivirals.
dc.contributor.author | O'Sullivan, Kathleen | |
dc.contributor.author | Levis, John | |
dc.contributor.author | Hegarty, Kevin G. | |
dc.contributor.author | Crosbie, Orla | |
dc.contributor.author | Kenny-Walsh, Elizabeth | |
dc.contributor.author | Fanning, Liam J. | en |
dc.date.accessioned | 2016-06-17T15:49:09Z | |
dc.date.available | 2016-06-17T15:49:09Z | |
dc.date.issued | 2012-07-14 | |
dc.date.updated | 2013-01-29T14:12:27Z | |
dc.description.status | Peer reviewed | en |
dc.description.version | Submitted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | O'Sullivan, K., Levis, J., Hegarty, K., Crosbie, O., Kenny-Walsh, E. and Fanning, L. J. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57, pp. 855–856. http://dx.doi.org/10.1002/hep.25942 | en |
dc.identifier.doi | 10.1002/hep.25942 | |
dc.identifier.endpage | 856 | en |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issn | 1527-3350 | |
dc.identifier.issued | 2 | en |
dc.identifier.journaltitle | Hepatology | en |
dc.identifier.startpage | 855 | en |
dc.identifier.uri | https://hdl.handle.net/10468/2759 | |
dc.identifier.volume | 57 | en |
dc.language.iso | en | en |
dc.publisher | Wiley | en |
dc.rights | © 2012 by the American Association for the Study of Liver Diseases. This is the pre-peer reviewed version of the following article: O’Sullivan et al. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57: 855–856, which has been published in final form at doi:10.1002/hep.25942. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | en |
dc.subject | HCV | en |
dc.subject | Hepacivirus | en |
dc.subject | Hepatitis C, | en |
dc.subject | Oligopeptides | en |
dc.subject | RNA | en |
dc.title | Clinical relevance of detectable HCV RNA in the context of direct acting antivirals. | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- HEP-13-1022.pdf
- Size:
- 60.66 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
Loading...
- Name:
- KOS_ClinicalSV2012.pdf
- Size:
- 186.63 KB
- Format:
- Adobe Portable Document Format
- Description:
- Submitted Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: